FDA Approves Children's DTaP-IPV Vaccine

Article

The FDA today approved a vaccine for active immunization against diphtheria, tetanus, pertussis, and poliomyelitis for children aged 4 to 6 years.

The FDA today approved a vaccine for active immunization against diphtheria, tetanus, pertussis, and poliomyelitis for children aged 4 to 6 years.

Quadracel combines the diphtheria and tetanus toxoids and acellular pertussis adsorbed vaccine (DTaP) and the inactivated poliovirus vaccine (IPV).

Quadrecel’s approval was based on the results of a phase 3 study, which demonstrated that Quadracel has a similar safety and immunogenicity profile as the DTaP vaccine and IPV when administered separately.

Side effects may include pain, redness, and swelling at the injection site, as well as muscle pain, fatigue, and headache. Patients also face a small risk of allergic reaction, according to Sanofi Pasteur, Quadracel’s manufacturer.

David P. Greenberg, MD, vice president of US Scientific and Medical Affairs at Sanofi Pasteur noted in a press release that Quadracel could reduce the number of vaccinations that children aged 4 to 6 need to receive.

“Our goal is to help remove barriers to timely immunization, and we think this combination vaccine could help ensure children are getting vaccinated in line with current recommendations,” Dr. Greenberg said.

Related Videos
Pride flags during pride event -- Image credit: ink drop | stock.adobe.com
Female Pharmacist Holding Tablet PC - Image credit: Tyler Olson | stock.adobe.com
African American male pharmacist using digital tablet during inventory in pharmacy - Image credit: sofiko14 | stock.adobe.com
Young woman using smart phone,Social media concept. - Image credit: Urupong | stock.adobe.com
selling mental health medication to man at pharmacy | Image Credit: Syda Productions - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Image credit: rawpixel.com | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.